Regional Cerebral Blood Flow in the Posterior Cingulate and Precuneus and the Entorhinal Cortical Atrophy Score Differentiate Mild Cognitive Impairment and Dementia Due to Alzheimer Disease

References

1. 1.↵
   2. Crous-Bou M,
   3. Minguillón C,
   4. Gramunt N, et al

   . Alzheimer's disease prevention: from risk factors to early intervention. Alzheimers Res Ther 2017;9:71 doi:10.1186/s13195-017-0297-z pmid:28899416

   CrossRefPubMed
2. 2.↵
   2. Tolppanen A-M,
   3. Taipale H,
   4. Purmonen T, et al

   . Hospital admissions, outpatient visits and healthcare costs of community-dwellers with Alzheimer's disease. Alzheimers Dement 2015;11:955–63 doi:10.1016/j.jalz.2014.10.005 pmid:25496872

   CrossRefPubMed
3. 3.↵
   2. Petersen RC

   . Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94 doi:10.1111/j.1365-2796.2004.01388.x pmid:15324362

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Apostolova LG

   . Alzheimer disease. Continuum (Minneap Minn) 2016;22:419–34 doi:10.1212/CON.0000000000000307 pmid:27042902

   CrossRefPubMed
5. 5.↵
   2. Sheelakumari R,
   3. Kesavadas C,
   4. Lekha VS, et al

   . Menon RN structural correlates of mild cognitive impairment: a clinicovolumetric study. Neurol India 2018;66:370–36 doi:10.4103/0028-3886.227298 pmid:29547157

   CrossRefPubMed
6. 6.↵
   2. Hays CC,
   3. Zlatar ZZ,
   4. Wierenga C

   . The utility of cerebral blood flow as a biomarker of preclinical Alzherimer's disease. Cell Mol Neurobiol 2016;36:167–79 doi:10.1007/s10571-015-0261-z pmid:26898552

   CrossRefPubMed
7. 7.↵
   2. Sandson TA,
   3. O'Connor M,
   4. Sperling RA, et al

   . Noninvasive perfusion MRI in Alzheimer's disease: a preliminary report. Neurology 1996;47:1339–42 doi:10.1212/WNL.47.5.1339 pmid:8909457

   Abstract/FREE Full Text
8. 8.↵
   2. Alsop DC,
   3. Detre JA,
   4. Grossman M

   . Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000;47:93–100 doi:10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8 pmid:10632106

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Johnson NA,
   3. Jahng G-H,
   4. Weiner MW, et al

   . Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005;234:851–59 doi:10.1148/radiol.2343040197 pmid:15734937

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Dai W,
    3. Lopez OL,
    4. Carmichael OT, et al

    . Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009;250:856–66 doi:10.1148/radiol.2503080751 pmid:19164119

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Binnewijzend MAA,
    3. Kuijer JPA,
    4. Benedictus MR, et al

    . Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 2013;267:221–30 doi:10.1148/radiol.12120928 pmid:23238159

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Bron EE,
    3. Steketee RME,
    4. Houston GC, et al

    . Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia. Hum Brain Mapp 2014;35:4916–31 doi:10.1002/hbm.22522 pmid:24700485

    CrossRefPubMed
13. 13.↵
    2. Sierra-Marcos A

    . Regional cerebral blood flow in mild cognitive impairment and Alzheimer's disease measured with arterial spin labeling magnetic resonance imaging. Int J Alzheimer's Dis 2017;2017:5479597 doi:10.1155/2017/5479597 pmid:28573062

    CrossRefPubMed
14. 14.↵
    2. Verclytte S,
    3. Lopes R,
    4. Delmaire C, et al

    . Optimization of brain perfusion image quality by cortical surface-based projection of arterial spin labeling maps in early-onset Alzheimer's disease patients. Eur Radiol 2015;25:2479–84 doi:10.1007/s00330-015-3652-0 pmid:25744625

    CrossRefPubMed
15. 15.↵
    2. Tosun D,
    3. Schuff N,
    4. Jagust W, et al

    ; Alzheimer's Disease Neuroimaging Initiative. Discriminative power of arterial spin labeling magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography changes for amyloid-beta-positive subjects in the Alzheimer's disease continuum. Neurodegener Dis 2016;16:87–94 doi:10.1159/000439257 pmid:26560336

    CrossRefPubMed
16. 16.↵
    2. Kaneta T,
    3. Katsuse O,
    4. Hirano T, et al

    . Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer's disease: a cross-sectional study. BMC Neurol 2017;17:91 doi:10.1186/s12883-017-0870-x pmid:28506213

    CrossRefPubMed
17. 17.↵
    2. Enkirch SJ,
    3. Traschütz A,
    4. Müller A, et al

    . The ERICA score: an MR imaging-based visual scoring system for the assessment of entorhinal cortex atrophy in Alzheimer disease. Radiology 2018;288:226–33 doi:10.1148/radiol.2018171888 pmid:29514015

    CrossRefPubMed
18. 18.↵
    2. Mathuranath PS,
    3. Hodges JR,
    4. Mathew R, et al

    . Adaptation of the ACE for a Malayalam speaking population in southern India. Int J Geriat Psychiatry 2004;19:1188–94 doi:10.1002/gps.1239 pmid:15526301

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Menon R,
    3. Lekha V,
    4. Justus S, et al

    . A pilot study on utility of Malayalam version of Addenbrooke′s Cognitive Examination in detection of amnestic mild cognitive impairment: a critical insight into utility of learning and recall measures. Ann Indian Acad Neurol 2014;17:420 doi:10.4103/0972-2327.144018 pmid:25506164

    CrossRefPubMed
20. 20.↵
    2. McKhann G,
    3. Drachman D,
    4. Folstein M, et al

    . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939–44 doi:10.1212/WNL.34.7.939 pmid:6610841

    Abstract/FREE Full Text
21. 21.↵
    2. Petersen RC,
    3. Stevens JC,
    4. Ganguli M, et al

    . Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review)—report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133–42 doi:10.1212/wnl.56.9.1133 pmid:11342677

    Abstract/FREE Full Text
22. 22.↵
    2. Alsop DC,
    3. Detre JA,
    4. Golay X, et al

    . Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM Perfusion Study group and the European Consortium for ASL in Dementia. Magn Reson Med 2015;73:102–16 doi:10.1002/mrm.25197 pmid:24715426

    CrossRefPubMed
23. 23.↵
    2. Yoshiura T,
    3. Hiwatashi A,
    4. Noguchi T, et al

    . Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer's disease. Eur Radiol 2009;19:2819–25 doi:10.1007/s00330-009-1511-6 pmid:19588145

    CrossRefPubMed
24. 24.↵
    2. Chao LL,
    3. Pa J,
    4. Duarte A, et al

    . Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI. Alzheimer Dis Assoc Disord 2009;23:245–52 doi:10.1097/WAD.0b013e318199ff46 pmid:19812467

    CrossRefPubMed
25. 25.↵
    2. Austin BP,
    3. Nair VA,
    4. Meier TB, et al

    . Effects of hypoperfusion in Alzheimer's disease. J Alzheimer's Dis 2011;26(Suppl 3):123–33 doi:10.3233/JAD-2011-0010 pmid:21971457

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Braak H,
    3. Braak E

    . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239–59 doi:10.1007/BF00308809

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Jessen F,
    3. Feyen L,
    4. Freymann K, et al

    . Volume reduction of the entorhinal cortex in subjective memory impairment. Neurobiol Aging 2006;27:1751–56 doi:10.1016/j.neurobiolaging.2005.10.010 pmid:16309795

    CrossRefPubMedWeb of Science
28. 28.↵
    2. deToledo-Morrell L,
    3. Stoub TR,
    4. Bulgakova M, et al

    . MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging 2004;25:1197–1203 doi:10.1016/j.neurobiolaging.2003.12.007 pmid:15312965

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Chen W,
    3. Song X,
    4. Beyea S, et al

    . Advances in perfusion magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement 2011;7:185–96 doi:10.1016/j.jalz.2010.04.004 pmid:21074500

    CrossRefPubMed
30. 30.↵
    2. Mazza M,
    3. Marano G,
    4. Traversi G, et al

    . Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. J Alzheimers Dis 2011;23:375–89 doi:10.3233/JAD-2010-090700 pmid:21098977

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Zhang Q,
    3. Stafford RB,
    4. Wang Z, et al

    . Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease. J Alzheimers Dis 2012;32:677–87 doi:10.3233/JAD-2012-120964

    CrossRefPubMed
32. 32.↵
    2. Alsop DC,
    3. Detre JA,
    4. Grossman M

    . Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000;47:93–100 doi:10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Espeseth T,
    3. Westlye LT,
    4. Fjell AM, et al

    . Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4. Neurobiol Aging 2008;29:329–40 doi:10.1016/j.neurobiolaging.2006.10.030 pmid:22886015

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Scheltens P,
    3. Leys D,
    4. Barkhof F, et al

    . Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967–72 doi:10.1136/jnnp.55.10.967 pmid:1431963

    Abstract/FREE Full Text
35. 35.↵
    2. Albert MS,
    3. DeKosky ST,
    4. Dickson D, et al

    . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270–79 doi:10.1016/j.jalz.2011.03.008 pmid:21514249

    CrossRefPubMedWeb of Science
36. 36.↵
    2. Landau SM,
    3. Horng A,
    4. Fero A, et al

    . Alzheimer's Disease Neuroimaging Initiative. Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI. Neurology 2016;86:1377–85 doi:10.1212/WNL.0000000000002576 pmid:26968515

    Abstract/FREE Full Text
37. 37.↵
    2. Sheelakumari R,
    3. Sarma SP,
    4. Kesavadas C, et al

    . Multimodality neuroimaging in mild cognitive impairment: a cross-sectional comparison study. Ann Indian Acad Neurol 2018;21:133–39 doi:10.4103/aian.AIAN_379_17 pmid:30122839

    CrossRefPubMed
38. 38.↵
    2. Alsop DC,
    3. Dai W,
    4. Detre JA, et al

    . Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J Alzheimers Dis 2010;20:871–80 doi:10.3233/JAD-2010-091699 pmid:20413865

    CrossRefPubMedWeb of Science